PTE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While PTE seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, PTE is valued expensive at the moment.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

PTE had negative earnings in the past year.
In the past year PTE has reported a negative cash flow from operations.

1.2 Ratios

PTE has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PTE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PTE has more shares outstanding
The debt/assets ratio for PTE has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -43.73, we must say that PTE is in the distress zone and has some risk of bankruptcy.
PTE has a Altman-Z score of -43.73. This is amonst the worse of the industry: PTE underperforms 91.49% of its industry peers.
PTE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-43.73

ROIC/WACCN/A

WACC9.96%

2.3 Liquidity

A Current Ratio of 4.11 indicates that PTE has no problem at all paying its short term obligations.
PTE has a Current ratio (4.11) which is in line with its industry peers.
PTE has a Quick Ratio of 4.11. This indicates that PTE is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 4.11, PTE perfoms like the industry average, outperforming 43.82% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	4.11
Quick Ratio	4.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.44%, which is quite impressive.
PTE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.66%.
Measured over the past years, PTE shows a very negative growth in Revenue. The Revenue has been decreasing by -47.73% on average per year.

EPS 1Y (TTM)61.44%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%74.22%

Revenue 1Y (TTM)-98.66%

Revenue growth 3Y-47.73%

Revenue growth 5YN/A

Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, PTE will show a very strong growth in Earnings Per Share. The EPS will grow by 28.11% on average per year.
PTE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 176.69% yearly.

EPS Next Y48.01%

EPS Next 2Y33.03%

EPS Next 3Y35.36%

EPS Next 5Y28.11%

Revenue Next Year-100%

Revenue Next 2Y179.39%

Revenue Next 3Y299.65%

Revenue Next 5Y176.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PTE. No positive earnings are expected for the next year.